News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
362,171 Results
Type
Article (15280)
Company Profile (77)
Press Release (346811)
Multimedia
Podcasts (23)
Webinars (5)
Section
Business (104397)
Career Advice (477)
Deals (21578)
Drug Delivery (31)
Drug Development (44548)
Employer Resources (66)
FDA (8485)
Job Trends (9453)
News (180587)
Policy (18893)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (1758)
Academic (1)
Accelerated approval (25)
Adcomms (9)
Allergies (85)
Alliances (22190)
ALS (86)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (194)
Approvals (8817)
Artificial intelligence (194)
Autoimmune disease (147)
Automation (17)
Bankruptcy (194)
Best Places to Work (8627)
BIOSECURE Act (4)
Biosimilars (82)
Biotechnology (49)
Bladder cancer (132)
Brain cancer (38)
Breast cancer (370)
Cancer (3047)
Cardiovascular disease (229)
Career advice (420)
Career pathing (6)
CAR-T (204)
CDC (48)
Celiac Disease (1)
Cell therapy (434)
Cervical cancer (19)
Clinical research (38552)
Collaboration (782)
Compensation (398)
Complete response letters (32)
COVID-19 (2969)
CRISPR (37)
C-suite (409)
Cystic fibrosis (78)
Data (4570)
Decentralized trials (2)
Denatured (6)
Depression (91)
Dermatology (46)
Diabetes (290)
Diagnostics (4112)
Digital health (20)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (101)
Drug pricing (44)
Drug shortages (9)
Duchenne muscular dystrophy (132)
Earnings (52477)
Editorial (28)
Employer branding (5)
Employer resources (58)
Events (55651)
Executive appointments (442)
FDA (10541)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (9)
Frontotemporal dementia (21)
Funding (571)
Gene editing (96)
Generative AI (7)
Gene therapy (281)
GLP-1 (476)
Government (3580)
Grass and pollen (1)
Guidances (360)
Healthcare (12747)
HIV (50)
Huntington's disease (15)
IgA nephropathy (65)
Immunology and inflammation (124)
Immuno-oncology (40)
Indications (104)
Infectious disease (3179)
Inflammatory bowel disease (118)
Inflation Reduction Act (4)
Influenza (97)
Intellectual property (176)
Interviews (84)
IPO (11710)
IRA (8)
Job creations (1160)
Job search strategy (360)
JPM (12)
Kidney cancer (12)
Labor market (31)
Layoffs (198)
Leadership (10)
Legal (3838)
Liver cancer (61)
Longevity (15)
Lung cancer (400)
Lymphoma (297)
Machine learning (17)
Management (28)
Manufacturing (382)
MASH (118)
Medical device (7570)
Medtech (7617)
Mergers & acquisitions (10658)
Metabolic disorders (726)
mRNA (135)
Multiple sclerosis (93)
NASH (7)
Neurodegenerative disease (165)
Neuropsychiatric disorders (38)
Neuroscience (1510)
NextGen: Class of 2026 (4689)
Non-profit (3278)
Now hiring (14)
Obesity (305)
Opinion (88)
Ovarian cancer (134)
Pain (122)
Pancreatic cancer (163)
Parkinson's disease (160)
Partnered (11)
Patents (344)
Patient recruitment (268)
Peanut (20)
People (29158)
Pharmaceutical (16)
Pharmacy benefit managers (10)
Phase 1 (11518)
Phase 2 (16818)
Phase 3 (13915)
Pipeline (5134)
Policy (128)
Postmarket research (1241)
Preclinical (4481)
Press Release (25)
Prostate cancer (177)
Psychedelics (16)
Radiopharmaceuticals (117)
Rare diseases (520)
Real estate (2445)
Recruiting (29)
Regulatory (14430)
Reports (19)
Research institute (1591)
Resumes & cover letters (65)
Rett syndrome (27)
RNA editing (4)
RSV (59)
Schizophrenia (99)
Series A (78)
Series B (52)
Service/supplier (7)
Sickle cell disease (60)
Special edition (11)
Spinal muscular atrophy (81)
Sponsored (15)
Startups (1380)
State (1)
Stomach cancer (3)
Supply chain (45)
Tariffs (23)
The Weekly (17)
Vaccines (907)
Venture capital (31)
Weight loss (171)
Women's health (51)
Worklife (7)
Date
Last 7 days (369)
Last 30 days (1224)
Last 365 days (15835)
2026 (5299)
2025 (15996)
2024 (19047)
2023 (22595)
2022 (30956)
2021 (35413)
2020 (35791)
2019 (37695)
2018 (23584)
2017 (14344)
2016 (12483)
2015 (16121)
2014 (10940)
2013 (8093)
2012 (9060)
2011 (9951)
2010 (8572)
Location
Africa (310)
Alabama (40)
Alaska (3)
Arizona (130)
Arkansas (5)
Asia (20980)
Australia (2849)
California (6988)
Canada (1561)
China (591)
Colorado (328)
Connecticut (331)
Delaware (209)
Europe (42663)
Florida (1301)
Georgia (232)
Idaho (26)
Illinois (564)
India (40)
Indiana (367)
Iowa (17)
Japan (279)
Kansas (83)
Kentucky (12)
Louisiana (20)
Maine (56)
Maryland (838)
Massachusetts (4796)
Michigan (140)
Minnesota (328)
Mississippi (2)
Missouri (62)
Montana (9)
Nebraska (13)
Nevada (68)
New Hampshire (55)
New Jersey (2301)
New Mexico (3)
New York (1989)
North Carolina (749)
North Dakota (5)
Northern California (3502)
Ohio (156)
Oklahoma (4)
Oregon (8)
Pennsylvania (1500)
Puerto Rico (12)
Rhode Island (18)
South America (500)
South Carolina (57)
South Dakota (1)
Southern California (2836)
Tennessee (101)
Texas (963)
United States (25051)
Utah (235)
Vermont (1)
Virginia (145)
Washington D.C. (35)
Washington State (605)
West Virginia (3)
Wisconsin (41)
Wyoming (1)
362,171 Results for "19".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to treat severe swelling episodes caused by the rare genetic disorder hereditary angioedema.
April 29, 2026
·
2 min read
·
Gabrielle Masson
Vaccines
Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment
COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Moderna is apparently also facing enrollment challenges.
April 2, 2026
·
2 min read
·
Nick Paul Taylor
Vaccines
Makary Denies FDA Plans To Levy Black Box Warning on COVID-19 Vaccines
Speaking on
Bloomberg TV
on Monday, FDA Commissioner Marty Makary contradicted recent reporting that suggested the agency was planning to add a black box label—its most serious warning—to COVID-19 vaccines.
December 16, 2025
·
3 min read
·
Heather McKenzie
Press Releases
GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026
April 29, 2026
·
2 min read
Vaccines
CDC Highlights Efficacy of COVID-19 Shots in Kids Amid FDA Probe of Alleged Deaths
The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care visits in children aged 9 months through four years, according to a new report.
December 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
April 29, 2026
·
3 min read
Regulatory
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
In the U.S., Moderna withdrew its approval application for the combination vaccine in May last year and the timeline for resubmission remains uncertain.
April 22, 2026
·
2 min read
·
Tristan Manalac
Vaccines
FDA To Provide Further Data on 10 Alleged Pediatric Deaths Linked to COVID-19 Vaccines By End of Month
Last week, Center for Biologics Evaluation and Research Director Vinay Prasad claimed in an internal memo—without providing evidence—that COVID-19 vaccines were responsible for the deaths of 10 children between 2021 and 2024.
December 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Countries with Seasonal Influenza Programs Achieved 2.5 Times Higher COVID-19 Vaccination Coverage, Study Finds
April 27, 2026
·
3 min read
Press Releases
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
April 23, 2026
·
9 min read
1 of 36,218
Next
